Invention Grant
- Patent Title: Bruton's tyrosine kinase inhibitors
-
Application No.: US16070520Application Date: 2017-01-17
-
Publication No.: US10662187B2Publication Date: 2020-05-26
- Inventor: Xibin Liao , Jia Li , Zhijian Lu , Yubo Zhou , Anhui Gao
- Applicant: Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. , Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Applicant Address: CN Zibo CN Shanghai
- Assignee: Zibo Biopolar Changsheng Pharmaceutical Co. Ltd.,Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Current Assignee: Zibo Biopolar Changsheng Pharmaceutical Co. Ltd.,Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Current Assignee Address: CN Zibo CN Shanghai
- Agency: SZDC Law P.C.
- International Application: PCT/US2017/013815 WO 20170117
- International Announcement: WO2017/127371 WO 20170727
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D231/56 ; A61K45/06 ; A61K31/437 ; A61K31/42 ; A61K31/4545 ; A61K31/496 ; A61K31/519 ; A61P35/00 ; A61P37/00
Abstract:
Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I):
Public/Granted literature
- US20190062328A1 BRUTON'S TYROSINE KINASE INHIBITORS Public/Granted day:2019-02-28
Information query
